Nu Skin Enterprises earnings release, August 10, 2026

Nu Skin Enterprises, Inc. (NUS) · Form 8-K, Item 2.02 · Filed · SEC filing

Nu Skin Enterprises Reports Second Quarter Results

PROVO, Utah — Aug. 10, 2026 — Nu Skin Enterprises

Inc. (NYSE: NUS) today announced second quarter results.

Executive Summary

Q2 2026 vs. Prior-year Quarter

“We continue to make progress toward our long-term strategy with the continued rollout of Prysm iO and preparations for the formal launch of India,” said Ryan Napierski, Nu

Skin president and CEO. “As these initiatives are taking hold, we are incorporating valuable learnings to strengthen our plans moving forward. At the same time, we are re-aligning our organizational resources to better position the business to drive sustainable, long-term value for our shareholders.”

Q2 2026 Year-over-year Operating Results

Stockholder Value

Q3 and Full-year 2026 Outlook

“

We delivered adjusted earnings per share near the midpoint of our guidance, reflecting our ongoing focus on profitability and disciplined execution,” said Chelsea Lantz, interim chief financial officer. “Based on our first-half performance and outlook for the rest of the year, we are updating our annual guidance to revenue of $1.28 billion to $1.35 billion and adjusted earnings per share of $0.70 to $0.90. For the third quarter, we expect revenue between $310 million and $340 million, with adjusted earnings per share in the range of $0.10 to $0.20.”

Conference Call

The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available on the same page through Aug. 24, 2026.

About Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc.

(NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

Financial statements

Income Statement

Q2 2026 Year-over-year Operating Results

$320.1 million compared to $386.1 million • (1.0)% FX impact or $(4.0) million – 68.2% compared to 68.8% • Nu Skin business was 77.7% compared to 77.5% – 33.7% compared to 33.2% • Nu Skin business was 39.8% compared to 40.0%
G&A Expenses28.4% compared to 27.6%
Operating Margin(18.5)% or 6.1% excluding non-cash impairment charge compared to 8.0%
Interest Expense$3.3 million compared to $2.5 million
Other Income (Expense)$(0.5) million compared to $(0.8) million
Income Tax Rate(295.4)% or 36.6% excluding non-cash tax charge compared to 23.0%
EPS$(5.14) or $0.20 excluding non-cash impairment and non-cash tax charges compared to $0.43

Income Statement

Three Months Ended June 30, — (U.S. dollars in thousands, except per share amounts)

Three Months Ended June 30,Three Months Ended June 30,Six Months Ended June 30,Six Months Ended June 30,
Revenue320,112386,138640,720750,628
Cost of sales101,787120,405207,932237,934
Gross profit218,325265,733432,788512,694
Operating expenses:Selling expenses107,922128,228217,976246,774
Operating expenses:General and administrative expenses90,847106,725189,391219,929
Operating expenses:Impairment expenses78,87580,71425,114
Operating expenses:Total operating expenses277,644234,953488,081491,817
Operating expenses:Operating income (loss)-59,31930,780-55,29320,877
Operating expenses:Interest expense3,3222,5267,5725,809
Operating expenses:Gain on sale of business176,162
Operating expenses:Other income (expense), net-534-8432,289-29,218
Operating expenses:Income (loss) before provision for income taxes-63,17527,411-60,576162,012
Operating expenses:Provision for income taxes186,6236,292187,38633,378
Operating expenses:Net income (loss)-249,79821,119-247,962128,634
Net income (loss) per share (Note 7):Basic-5.140.43-5.122.59
Net income (loss) per share (Note 7):Diluted-5.140.43-5.122.59
Weighted-average common shares outstanding (000s):Basic48,59649,44148,40049,601
Weighted-average common shares outstanding (000s):Diluted48,59649,49948,40049,748

Income Statement

Three months ended June 30, — (in thousands, except for per share amounts)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
Operating Income-59,31930,780-55,29320,877
Impact of inventory write-off3,116
Impact of other charges(1)2,6437,966
Impact of impairment78,87580,71425,114
Adjusted operating income19,55630,78031,18053,957
Operating margin-18.5%8-8.6%2.8
Operating margin, excluding certain charges6.1%84.9%7.2
Revenue320,112386,138640,720750,628

Income Statement

Three months ended June 30, — (in thousands, except for per share amounts)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
Provision (benefit) for income taxes186,6236,292187,38633,378
Impact of inventory write-off on provision for income taxes1,065
Impact of other charges(1) on provision for income taxes903725
Impact of impairment on provision for income taxes-13,370-12,7415,433
Impact of gain on Mavely sale on provision for income taxes-31,104
Impact of gain on unrealized investment loss on provision for income taxes6,074
Impact of valuation allowance on deferred tax assets-167,505-167,505
Provision for income taxes, excluding impact of certain charges5,7486,2929,10814,506
Income before provision for income taxes-63,17527,411-60,576162,012
Impact of inventory write-off3,116
Impact of other charges(1)2,6437,966
Impact of impairment expense:78,87580,71425,114
Impact of gain on Mavely sale-176,162
Impact of unrealized investment loss28,077
Income before provision for income taxes, excluding impact certain charges15,70027,41125,89747,007
Effective tax rate-295.4%23-309.3%20.6
Effective tax rate, excluding impact of certain charges36.6%2335.2%30.9

Income Statement

Three months ended June 30, — (in thousands, except for per share amounts)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
Net income-249,79821,119-247,962128,634
Impact of Inventory write-offInventory write-off3,116
Impact of Inventory write-offTax impact-1,065
Impact of other chargesOther charges2,6437,966
Impact of other chargesTax impact-903-725
Impact of impairmentImpairment charges78,87580,71425,114
Impact of impairmentTax impact13,37012,741-5,433
Impact of Mavely saleMavely sale-176,162
Impact of Mavely saleTax impact31,104
Impact of unrealized investment lossUnrealized investment loss28,077
Impact of unrealized investment lossTax impact-6,074
Impact of unrealized investment lossImpact of valuation allowance on deferred tax assets167,505167,505
Impact of unrealized investment lossAdjusted net income9,95221,11916,78932,501
Impact of unrealized investment lossDiluted earnings per share-5.140.43-5.122.59
Impact of unrealized investment lossDiluted earnings per share, excluding impact of certain charges0.20.430.350.65

Balance Sheet

June 30, 2026 — (U.S. dollars in thousands)

June 30, 2026December 31, 2025
Current assets:Cash and cash equivalents189,643238,630
Current assets:Current investments1,7431,211
Current assets:Accounts receivable, net48,90239,544
Current assets:Inventories, net191,497178,643
Current assets:Prepaid expenses and other76,36489,670
Current assets:Total current assets508,149547,698
Current assets:Property and equipment, net379,550377,168
Current assets:Operating lease right-of-use assets65,44274,021
Current assets:Goodwill4,75083,625
Current assets:Other intangible assets, net37,88442,614
Current assets:Other assets125,755280,187
Current assets:Total assets1,121,5301,405,313
Current liabilities:Accounts payable37,71126,183
Current liabilities:Accrued expenses198,636217,551
Current liabilities:Current portion of long-term debt20,00020,000
Current liabilities:Total current liabilities256,347263,734
Current liabilities:Operating lease liabilities50,07557,640
Current liabilities:Long-term debt193,664204,187
Current liabilities:Other liabilities78,70574,512
Current liabilities:Total liabilities578,791600,073
Stockholders’ equity:Class A common stock – 500 million shares authorized, $0.001 par value, 90.6 million shares issued9191
Stockholders’ equity:Additional paid-in capital612,412635,994
Stockholders’ equity:Treasury stock, at cost – 41.9 million and 42.4 million shares-1,558,183-1,575,059
Stockholders’ equity:Accumulated other comprehensive loss-118,152-116,105
Stockholders’ equity:Retained earnings1,606,5711,860,319
Stockholders’ equity:Total stockholders' equity542,739805,240
Stockholders’ equity:Total liabilities and stockholders’ equity1,121,5301,405,313
Full release

Important Information Regarding Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, initiatives, shareholder value, Prysm launch and its timing, and India expansion; projections regarding revenue, expenses, margins, tax rates, earnings per share, foreign currency fluctuations, uses of cash, financial position and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as

“believe,” “expect,” “become,” “drive,” “project,” “outlook,” “guidance,” “will,” “would,” “could,” “may,” “might,” the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

The company’s financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company’s beliefs as of the date that such information was first provided, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

Non-GAAP Financial Measures:

Constant-currency revenue change is a non-GAAP financial measure that removes the impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the company’s performance. It is calculated by translating the current period’s revenue at the same average exchange rates in effect during the applicable prior-year period and then comparing that amount to the prior-year period’s revenue. The company believes that constant-currency revenue change is useful to investors, lenders and analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company’s revenue from period to period.

Earnings per share, operating margin, and income tax rate, each excluding impairment charges, tax charges, and/or other charges, also are non-GAAP financial measures.

The company believes that these non-GAAP financial measures are useful to investors, lenders and analysts because removing the impact of these items... (truncated)se items to our earnings per share, gross margin, operating margin, income tax rate and revenue growth rate calculated under GAAP, below.

The following table sets forth revenue for the three-month periods ended June 30, 2026, and 2025 for each of our reportable segments (U.S. dollars in thousands):

The following table sets forth revenue for the six-month periods ended June 30, 2026, and 2025 for each of our reportable segments (U.S. dollars in thousands):

The following tables provide information concerning the number of Customers, Paid Affiliates and Sales Leaders in our core Nu Skin business for the three-month periods ended June 30, 2026 and 2025.

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Income (Unaudited)

(U.S. dollars in thousands, except per share amounts)

NU SKIN ENTERPRISES, INC.

Consolidated Balance Sheets (Unaudited)

(U.S. dollars in thousands)

NU SKIN ENTERPRISES, INC.

Reconciliation of Operating Margin Excluding Certain Charges to GAAP Operating Margin

(in thousands, except for per share amounts)

(1) Other charges for the first quarter of 2026 consist of $1.0 million related to the wind down of the separate BeautyBio business and $1.6 million of other employee severance charges. Other charges for the first quarter of 2025 consist of expenses incurred in connection with the Mavely sale, including $2.7 million of transaction bonuses for certain employees and $5.2 million of equity compensation as a result of the vesting of the Mavely profits interest units.

NU SKIN ENTERPRISES, INC.

Reconciliation of Effective Tax Rate Excluding Impact of Certain Charges to GAAP Effective Tax Rate

(in thousands, except for per share amounts)

NU SKIN ENTERPRISES, INC.

Reconciliation of Earnings Per Share Excluding Impact of Certain

Charges to GAAP Earnings Per Share

(in thousands, except for per share amounts)

NU SKIN ENTERPRISES, INC.

Reconciliation of Earnings Per Share Excluding Impact of Certain Charges to GAAP Earnings Per Share

(2) We are currently anticipating other charges for the third quarter of 2026 of approximately $5 million in cash-based transition cost. Other charges for the first quarter of 2026 consist of $1.0 million related to the wind down of the separate BeautyBio business and $1.6 million of other employee severance charges.

# # #

CONTACTS:

Media: media@nuskin.com, (801) 345-6397

Investors: investorrelations@nuskin.com, (801) 345-3577

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.